Obesity & Metabolic

Weight-Loss Drugs: How Pharmacology Fights Obesity

For decades, weight-loss drugs were weak, risky, or both. Then a class you already know — the GLP-1 agonists from the diabetes chapter — changed everything, producing weight loss once only possible with surgery. Understanding how they and the other agents work shows why obesity is finally being treated as the metabolic disease it is.

Gout: Two Completely Different Jobs for the Drugs

Gout is caused by needle-sharp uric acid crystals forming in a joint, triggering agonising attacks. The single most important idea in treating it is that the drugs split into two opposite camps — those that calm an acute attack and those that prevent future ones — and giving the wrong type at the wrong time can make things dramatically worse.

Metabolic Syndrome: When the Diseases Travel Together

Obesity, type 2 diabetes, high blood pressure and abnormal cholesterol are usually taught as separate topics, but in real patients they cluster together astonishingly often. This 'metabolic syndrome' is the thread running through much of this whole section — and seeing it explains why the modern drugs that treat one of these problems so often help the others too.